269 related articles for article (PubMed ID: 25096718)
1. Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells.
Hindupur SK; Balaji SA; Saxena M; Pandey S; Sravan GS; Heda N; Kumar MV; Mukherjee G; Dey D; Rangarajan A
Breast Cancer Res; 2014 Aug; 16(4):420. PubMed ID: 25096718
[TBL] [Abstract][Full Text] [Related]
2. The protein phosphatase 4 - PEA15 axis regulates the survival of breast cancer cells.
Mohammed HN; Pickard MR; Mourtada-Maarabouni M
Cell Signal; 2016 Sep; 28(9):1389-1400. PubMed ID: 27317964
[TBL] [Abstract][Full Text] [Related]
3. Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling.
Ishikawa F; Ushida K; Mori K; Shibanuma M
Cell Death Dis; 2015 Jan; 6(1):e1619. PubMed ID: 25611393
[TBL] [Abstract][Full Text] [Related]
4. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ
Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305
[TBL] [Abstract][Full Text] [Related]
6. Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.
Park J; Tacam MJ; Chauhan G; Cohen EN; Gagliardi M; Iles LR; Ueno NT; Battula VL; Sohn YK; Wang X; Kim HS; Krishnamurthy S; Fowlkes NW; Green MM; Bartholomeusz GA; Tripathy D; Reuben JM; Bartholomeusz C
Breast Cancer Res Treat; 2021 Sep; 189(2):333-345. PubMed ID: 34241740
[TBL] [Abstract][Full Text] [Related]
7. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
[TBL] [Abstract][Full Text] [Related]
8. ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
Khan IA; Yoo BH; McPhee M; Masson O; Surette A; Dakin-Hache K; Younis T; Bethune G; Rosen KV
Breast Cancer Res; 2018 Dec; 20(1):151. PubMed ID: 30545388
[TBL] [Abstract][Full Text] [Related]
9. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells.
Huang W; Gonzalez ME; Toy KA; Banerjee M; Kleer CG
Cancer Res; 2010 Apr; 70(8):3340-50. PubMed ID: 20395207
[TBL] [Abstract][Full Text] [Related]
11. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.
Vitolo MI; Weiss MB; Szmacinski M; Tahir K; Waldman T; Park BH; Martin SS; Weber DJ; Bachman KE
Cancer Res; 2009 Nov; 69(21):8275-83. PubMed ID: 19843859
[TBL] [Abstract][Full Text] [Related]
12. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
[TBL] [Abstract][Full Text] [Related]
13. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
Tang B; Liang W; Liao Y; Li Z; Wang Y; Yan C
Oncol Rep; 2019 Jan; 41(1):43-56. PubMed ID: 30365128
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15.
Bartholomeusz C; Itamochi H; Nitta M; Saya H; Ginsberg MH; Ueno NT
Oncogene; 2006 Jan; 25(1):79-90. PubMed ID: 16170361
[TBL] [Abstract][Full Text] [Related]
15. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
16. Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis.
Wei L; Yang Y; Zhang X; Yu Q
J Cell Biochem; 2002; 87(4):439-49. PubMed ID: 12397603
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.
Chen MB; Zhang Y; Wei MX; Shen W; Wu XY; Yao C; Lu PH
Cell Signal; 2013 Oct; 25(10):1993-2002. PubMed ID: 23712032
[TBL] [Abstract][Full Text] [Related]
18. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.
Zhang H; Fredericks T; Xiong G; Qi Y; Rychahou PG; Li JD; Pihlajaniemi T; Xu W; Xu R
Breast Cancer Res; 2018 Oct; 20(1):116. PubMed ID: 30285809
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
Klopp AH; Lacerda L; Gupta A; Debeb BG; Solley T; Li L; Spaeth E; Xu W; Zhang X; Lewis MT; Reuben JM; Krishnamurthy S; Ferrari M; Gaspar R; Buchholz TA; Cristofanilli M; Marini F; Andreeff M; Woodward WA
PLoS One; 2010 Aug; 5(8):e12180. PubMed ID: 20808935
[TBL] [Abstract][Full Text] [Related]
20. Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a.
Rutherford TR; Elder AM; Lyons TR
Cell Death Dis; 2021 Sep; 12(10):872. PubMed ID: 34561423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
